- | Country : -
- | organs : -
- | Specialty : -
Extract
Demonstrate that treatment with degarelix in terms of mean percentage reduction in prostate volume measured with trans-rectal ultrasound (TRUS) is non-inferior to treatment with goserelin plus bicalutamide at 12 weeks compared to baseline
Inclusion criteria
- Prostate cancer